Most leaders are so preoccupied with the health/well-being and engagement of their teams, they forget the steps necessary to take care of themselves. Photo via Pexels

Age-old advice for stressed caregivers typically shared by concerned friends and relatives is ‘take care of yourself first or you won’t have anything left for others.’ With or without the advice, many caregivers continue to selflessly do for others at the expense of their own health and well-being because it is in their DNA.

The workplace is no exception, especially for workers in leadership roles who have supported the emotional and physical needs of their staff nonstop for two years. Many leaders, from CEOs to frontline managers, have not only dealt with their own issues as a result of the pandemic, but also those of their teams, leaving them exhausted and suffering from compassion fatigue because they failed to follow their own advice.

Below are four ways leaders can manage compassion fatigue.

Lead by example

Leaders have spent countless time promoting company policies, programs and benefits that help employees deal with increased levels of stress in their professional and personal lives, which can have an impact on mental health and well-being. One of the first things leaders should do is set an example by utilizing the programs themselves to address compassion fatigue. Practicing what they preach not only supports the mental well-being of leaders, but it also demonstrates a culture that cares about mental health issues. Taking the initiative can encourage peers and others to take advantage of a company’s employee-support mechanisms.

Take time off

There are numerous reasons why many leaders are hesitant about taking time off, but the most common reasons are fear of being viewed as dispensable or worry that work will not get completed. It is not unusual for leaders to carry over weeks of PTO, or even lose it completely rather than use it. Disconnecting from work by taking time off is critical for renewal and emotional health that leads to rejuvenated leaders who are highly engaged and more motivated to lead their teams. While taking time off benefits leaders, it also builds confidence in staff because they recognize the trust that has been placed in them while the boss is gone.

Reach out to HR

Based on the widespread occurrence of compassion fatigue, chances are other leaders are experiencing the same feelings. Reaching out to HR can help get the ball rolling for additional programs designed to support leaders. For example, hosting lunch-and-learn sessions with medical professionals for advice, offering training sessions that cover relaxation methods, and creating a buddy system that pairs leaders for increased connections and mutual support. When leaders throughout the company realize they are not alone, they will feel more comfortable seeking help and participating in company-sponsored programs.

Develop a peer-to-peer accountability system

For higher-level executives who report directly to busy CEOs or a board of directors, there are fewer levels of oversight to address compassion fatigue. In fact, these may be the very individuals in most need of support. Executive teams should develop peer-to-peer accountability systems to support each other via biweekly mental health check-up chats, periodic PTO usage updates, quarterly retreats with dedicated downtime to relax, and weekly walking meetings. When executive teams create accountability systems, it helps to support mental health and well-being, build greater trust, and nurture stronger relationships that position leaders to better serve the organization.

It is no surprise that most leaders are so preoccupied with the health/well-being and engagement of their teams, they forget the steps necessary to take care of themselves. Leaders who embrace a popular philosophy – as go the leaders, so goes the culture and the company – should feel compelled to combat compassion fatigue by leading by example, taking time off, reaching out to HR and developing peer-to-peer accountability systems, putting their best selves forward to serve the needs of their teams and organization.

------

Sherry Waters is vice president of field operations for Houston-based Insperity, a leading provider of human resources and business performance solutions.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.